scispace - formally typeset
A

Akira Miyazato

Researcher at University of Tokyo

Publications -  18
Citations -  641

Akira Miyazato is an academic researcher from University of Tokyo. The author has contributed to research in topics: Proto-oncogene tyrosine-protein kinase Src & TEC. The author has an hindex of 11, co-authored 18 publications receiving 621 citations.

Papers
More filters
Journal ArticleDOI

Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction.

TL;DR: Examination of the Blast Bank samples from 22 patients with MDS, 31 with AML, and 8 with chronic myeloid leukemia confirmed the highly selective expression of the Dlk gene, which could be the first candidate molecule to differentiate MDS from AML.
Journal ArticleDOI

SOCS-1/JAB/SSI-1 Can Bind to and Suppress Tec Protein-tyrosine Kinase *

TL;DR: It is proposed that SOCS- 1/JAB/SSI-1/TIP3 is a novel type of negative regulator to a subset of protein-tyrosine kinases to obscure how Tec relays the signals from cell surface receptors to the nucleus.
Journal ArticleDOI

Molecular cloning of a docking protein, BRDG1, that acts downstream of the Tec tyrosine kinase

TL;DR: BRDG1 appears to function as a docking protein acting downstream of Tec in BCR signaling, and was shown to participate in a positive feedback loop by increasing the activity of Tec.
Journal ArticleDOI

Tec and Jak2 Kinases Cooperate to Mediate Cytokine-Driven Activation of c-fos Transcription

TL;DR: It is presented here that Tec PTK is tyrosine-phosphorylated and activated by granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulation in a human GM- CSF–dependent cell line and that Tec and Jak2 can “cross-talk” in a complexed way to mediate cytokine-driven c- fos activation.
Journal ArticleDOI

Severe hepatitis and complete molecular response caused by imatinib mesylate: possible association of its serum concentration with clinical outcomes.

TL;DR: Results suggest that both hepatitis and molecular response were associated with the serum STI571 concentration, which is consistent with drug-induced hepatitis.